Related by context. Frequent words. (Click for all words.) 73 Continued Listing 72 Minimum Bid Price 70 Option Grants 69 Q2 Loss Narrows 68 Commences Trading 68 Extends Tender Offer 68 Q1 Loss Narrows 67 THE TREND CONTINUES DOWN 67 Q2 Loss Widens 67 Q3 Loss Narrows 67 Annual Meeting Date 67 Symbol Change 67 Guides FY# Quick Facts 66 Receives Notice 66 Options Trader Alert 66 Q4 Loss Widens 66 Announces Definitive Agreement 66 Q1 Loss Widens 66 Share Repurchases 66 Non Compliance 66 Completes Enrollment 66 Q4 Loss Narrows 66 Provides Guidance 65 Q3 Loss Widens 65 Shelf Registration Statement 65 Bullish Engulfing Pattern 65 Updates Guidance 65 NASDAQ Listing Rule 65 THE TREND CONTINUES LOWER 65 Announces Share Repurchase 65 NASDAQ Listing 65 #.#/Share [002] 64 Nasdaq Listing Rule 64 SET TO POSSIBLY PULLBACK 64 Posts Large 64 Interesting Options Volume 64 NASDAQ SmallCap 64 Previously Announced 64 Announces Intent 64 SMARTREND DETECTS CONTINUED BUYING 64 RPRX 64 Lowers Guidance 64 Announces Termination 64 SHARES COULD POTENTIALLY PULLBACK 64 WEEK HIGH RECENTLY ECLIPSED 64 LOOKS TO CONTINUE TO 63 Issues Guidance 63 READ THE PROXY 63 Files Registration Statement 63 Complete Merger 63 Winning Streak Continues 63 FDA Clears 63 Complies 63 Updates Shareholders 63 SEE CONTINUED UPWARD MOMENTUM 63 ticker symbol SLXP 63 Provide Comprehensive 63 Announces Organizational Changes 63 Record Second Quarter 63 Announces Issuance 63 Shareholder Approval 63 Announces Stock Repurchase 63 Completes Merger 63 Declares Regular Quarterly Dividend 63 Announces Revised 62 BULLISH MOVING AVERAGE CROSSOVER 62 Announces Cash Dividend 62 Shareholder Vote 62 Record Third Quarter 62 Stockholders Approve 62 Completes Private Placement 62 Announces Redemption 62 OFFERS INVESTORS BETTER VALUE 62 Proposed Rule Change 62 Declares Cash Dividend 62 Successful Completion 62 Cent Dividend 62 Declares Quarterly Cash Dividend 62 Trading Halt 62 EpiCept Corporation 62 Updates Status 62 Shareholders Approve Merger 62 Commences Tender Offer 62 Declares Quarterly Dividends 62 Listing Requirements 62 Drug Candidate 62 Salix trades 62 Initiates Phase 62 2nd Quarter Results 62 SHARES COULD PULLBACK 61 Clinical Trial Results 61 Guides Above 61 Adopts Shareholder Rights 61 ITS REGULATION SERVICES PROVIDER 61 L.P. 61 Announces Filing 61 Late Filing 61 Announces Receipt 61 Immunicon Corporation 61 Mln Common 61 Bearish Pressure Building